TNYA — Tenaya Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Ardelyx, Nvidia, Bath & Body Works
Tenaya Therapeutics drops on pricing $75 mln share offering
Brief: Tenaya Therapeutics Announces Pricing Of Public Offering Of 22.61 Mln Common Shares Priced At $2.60 Per Share
Tenaya Therapeutics tumbles on stock offering
Brief: Tenaya Therapeutics Announces Proposed Public Offering
Brief: Tenaya Therapeutics Reports Q3 2022 Financial Results And Provides Business Update
Brief: Tenaya Therapeutics Announces FDA Clearance Of Investigational New Drug Application
Brief: Tenaya Therapeutics May Offer, Sell Shares Of Common Stock Of Up To $75 Mln Through SVB Securities
Brief: Tenaya Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million
Brief: Tenaya Therapeutics Q2 Loss Per Share $0.69
Brief: Tenaya Therapeutics Launches Operations Of New Genetic Medicines Manufacturing Center To Support Development Of Potentially First-In-Class Cardiovascular Therapeutics
NASDAQ RESUMED AT 10:26 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:22 AM
Brief: Tenaya Therapeutics Reports First Quarter 2022 Results
Brief: Tenaya Therapeutics Reports Fourth Quarter And Year-End 2021 Results
Brief: Tenaya Therapeutics Says IND Applications For TN-201 And TN-301 Expected To Be Submitted In H2 Of 2022
Brief: Tenaya Therapeutics Appoints Karah Parschauer, J.D., To Its Board Of Directors And Joanna Auch As Senior Vice President Of People And Culture
Brief: Tenaya Therapeutics Posts Q3 Loss Per Share Of $0.68
Tenaya Therapeutics Inc reports results for the quarter ended in June - Earnings Summary